# Clustering Approach 5 : MRNASEQ_CHIERARCHICAL
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	2.8708202967298e-05	Range of duration = 0.03 to 223.96, nDeath = 75, nCensor = 139
2	AGE	ANOVA	0.19652714347423	Range of values = 38 to 86, Mean = 65.4626, StdDev = 9.72225, nMissing = 26
3	GENDER	Chi-square test	6.44828392309098e-06	nTypes = 2 (FEMALE/MALE), nPatients = 110/130
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.576069608511756	Range of values = 0 to 100, Mean = 69.4444, StdDev = 39.0282, nMissing = 222
5	HISTOLOGICAL.TYPE	Chi-square test	0.000331255370625637	nTypes = 11 (LUNG ACINAR ADENOCARCINOMA/LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS/LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS/LUNG CLEAR CELL ADENOCARCINOMA/LUNG MICROPAPILLARY ADENOCARCINOMA/LUNG MUCINOUS ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA/LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA/MUCINOUS (COLLOID) ADENOCARCINOMA), nPatients = 3/52/156/3/8/2/2/2/9/1/2
6	PATHOLOGY.T	Chi-square test	0.089759562236612	nTypes = 4 (T1/T2/T3/T4), nPatients = 61/144/21/13, nMissing = 1
7	PATHOLOGY.N	Chi-square test	0.00174827070820038	nTypes = 3 (N0/N1/N2+N3), nPatients = 136/53/46, nMissing = 5
8	PATHOLOGICSPREAD(M)	Chi-square test	0.487521079487291	nTypes = 3 (M0/M1/MX), nPatients = 176/12/46, nMissing = 6
9	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.66116529295297	nTypes = 2 (NO/YES), nPatients = 229/11
10	NEOADJUVANT.THERAPY	Chi-square test	0.165958154029911	nTypes = 2 (NO/YES), nPatients = 203/37